miR-142-5p regulates tumor cell PD-L1 expression and enhances anti-tumor immunity

Biochemical and Biophysical Research Communications
Long JiaRongxin Zhang

Abstract

Cancer immunotherapy has many great achievements in recent years. One of the most promising cancer immunotherapies is PD-1/PD-L1 pathway blockade. miRNAs (MicroRNAs) belongs to small noncoding RNA and can regulate gene expression by binding to the 3'UTR. Many miRNAs can inhibit cancer growth by regulating the PD-L1 expression in cancer cells. Herein, we firstly found that PD-L1 could be the target of miR-142-5p by using bioinformatics methods, then we conduct luciferase activity assay, RT-PCR and western blot experiments to demonstrate that miR-142-5p can regulate PD-L1 expression by binding to its 3'UTR. And in vivo experiments certified that miR-142-5p overexpression can inhibit pancreatic cancer growth. Flow cytometry and RT-PCR experiment demonstrated that miR-142-5p overexpression on tumor cells inhibits the expression of PD-L1 on tumor cells which result in the increase of CD4+ T lymphocytes and CD8+ T lymphocytes, the decrease of PD-1+ T lymphocytes and increase of IFN-γ and TNF-α. So, miR-142-5p overexpression can enhance anti-tumor immunity by blocking PD-L1/PD-1 pathway. Our results identify a novel mechanism by which PD-L1 is regulated by miR-142-5p and overexpression of miR-142-5p could enhance the anti-tumor immunity.

Citations

Dec 1, 2017·International Journal of Molecular Sciences·Qingshui WangHang Fai Kwok
Sep 8, 2018·Journal of Cellular Physiology·Fatemeh K DermaniRezvan Najafi
Oct 27, 2018·Journal of Cellular Physiology·Adeleh TaghikhaniSeyyed-Mohammad Moazzeni
May 6, 2019·International Journal of Molecular Sciences·Natalia García-SanchaJavier Cañueto
Apr 3, 2020·Journal of Cellular Physiology·Nirvana Kalantari KhandaniSeyed Isaac Hashemy
Dec 23, 2017·Cancer Metastasis Reviews·Gabriele Romano, Lawrence N Kwong
Nov 22, 2019·Pathology Oncology Research : POR·Lei DingYanli Li
Mar 31, 2020·Journal of Hematology & Oncology·Ming YiKongming Wu
Jun 21, 2020·Signal Transduction and Targeted Therapy·Lei LiuShouping Xu
Jul 22, 2020·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Hui Li, Junhong Jiang
Jul 28, 2020·Biomolecules·Alexandre PerrierSimon Garinet
Jan 17, 2019·Molecular Cancer·Xianjie JiangZhaoyang Zeng
Dec 14, 2018·Pharmacogenomics·Jiancheng SuSongshan Jiang
Mar 13, 2020·Frontiers in Cell and Developmental Biology·Silvia PesceEmanuela Marcenaro
Sep 16, 2020·Cell Death & Disease·Caterina CostaAntonio Giordano
Aug 19, 2018·Cancer Immunology, Immunotherapy : CII·Yongyu Shi
Jul 27, 2018·Canadian Journal of Gastroenterology & Hepatology·Yixin YangWei Wang
Nov 18, 2018·Frontiers in Immunology·Ning YangJingtao Chen
Dec 24, 2018·Therapeutic Advances in Medical Oncology·Federico Pio FabrizioLucia Anna Muscarella
Jul 2, 2019·Frontiers in Immunology·Xiangfeng ShenZhi-Xiang Xu
Apr 23, 2020·International Journal of Molecular Sciences·Marta GomarascaGiovanni Lombardi
Oct 22, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Giuliana AmatoSebastiano Gangemi
May 18, 2020·International Immunopharmacology·Gholamreza Rezaei DanbaranHamed Mohammadi
Feb 16, 2021·The AAPS Journal·Akhil SrivastavaRajagopal Ramesh
Jan 9, 2021·Journal of Hematology & Oncology·Ming YiKongming Wu
Jan 23, 2021·Journal of Controlled Release : Official Journal of the Controlled Release Society·David VetvickaDavid Oupický
Mar 7, 2021·International Journal of Molecular Sciences·Rebecca RaueBernhard Brüne
Oct 6, 2018·Trends in Biochemical Sciences·Jinfang ZhangWenyi Wei
Jan 18, 2018·Experimental and Molecular Pathology·Farhadul IslamAlfred K-Y Lam

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.